Cite
MLA Citation
Youn H Kim et al.. “Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.” Lancet oncology, vol. 19, no. 9, 2018, pp. 1192–1204. http://access.bl.uk/ark:/81055/vdc_100066657965.0x000011